Stock-Based Compensation (Details)		1 Months Ended	12 Months Ended
	Feb. 16, 2021 USD ($)	Dec. 31, 2019 USD ($) shares	Dec. 31, 2021 USD ($) $ / shares shares	Dec. 31, 2020 USD ($) shares	Mar. 26, 2021	Aug. 18, 2020
Stock-Based Compensation (Details) [Line Items]
Exchange ratio			0.4047
Amount of remitted				$ 11,900,000
Stock-based compensation expense				800,000
Option to purchase shares (in Shares) | shares		922,221
Stock-based compensation expense description		$ 7,400,000	$ 14,814,000	17,909,000
Over weighted average period		1 year 4 months 24 days
Weighted average period			10 months 24 days
Selling and general expenses			$ 10,700,000
Base full value award, percentage			3.00%
Deemed grant of PSU shares, percentage			15.00%
Award expense			$ 1,900,000	800,000
Expense for RSUs			6,400,000	10,700,000
Intrinsic value of the outstanding RSUs			$ 4,100,000	$ 0
Granted shares (in Shares) | shares
Unrecognized compensation expense cost			$ 12,400,000
Weighted-average vesting period			2 years 8 months 12 days
Option expenses			$ 100,000	$ 0
Intrinsic value of the options exercised			100,000	38,400,000
Intrinsic value of the RSUs vested			3,500,000	10,700,000
Intrinsic value of outstanding option			$ 0	7,400,000
Business Combination [Member]
Stock-Based Compensation (Details) [Line Items]
Percentage of award stock units					100.00%	1.35%
Restricted Stock Units (RSUs) [Member]
Stock-Based Compensation (Details) [Line Items]
Granted number of shares (Restricted Stock Units) (in Shares) | shares			4,484,383
Granted shares (in Shares) | shares			5,850,151
Performance Shares [Member]
Stock-Based Compensation (Details) [Line Items]
Granted number of shares (Performance Stock Units) (in Shares) | shares			1,197,140
Granted shares (in Shares) | shares			2,628,868
Expense for PSUs			$ 900,000	0
ESPP [Member]
Stock-Based Compensation (Details) [Line Items]
Stock-based compensation expense			100,000
Chief Executive Officer [Member]
Stock-Based Compensation (Details) [Line Items]
Liability-based awards accrued				$ 4,200,000
Additional cash liability	$ 1,700,000
Total cash liability			5,900,000
Grant date fair value			2,700,000
Class A Common Stock [Member]
Stock-Based Compensation (Details) [Line Items]
Amount of repurchased			$ 11,900,000
Future Granted number of shares (in Shares) | shares			1,621,563
Employees have purchased shares (in Dollars per share) | $ / shares			$ 143,353
Outstanding expense			$ 700,000
Maximum [Member]
Stock-Based Compensation (Details) [Line Items]
Weighted average period			5 years
Access Physicians Replacement Awards [Member]
Stock-Based Compensation (Details) [Line Items]
Recognized Expense			$ 1,300,000
Compensation expense			$ 800,000
2014 Equity Incentive Plan [Member]
Stock-Based Compensation (Details) [Line Items]
Equity incentive plan, description			The total number of shares of Class A common stock reserved for awards under the 2020 Plan initially equaled 11% of the fully diluted capitalization of the Company as of the closing of the Merger Transaction, or 9,707,040 shares of Class A common stock.
2020 Plan [Member]
Stock-Based Compensation (Details) [Line Items]
Equity incentive plan, description			(i) 5% of the outstanding shares on the last day of the immediately preceding fiscal year and (ii) such number of shares as determined by the Board. On January 1, 2021, an additional 3,838,275 shares were automatically made available for issuance under the 2020 Plan, which represented 5% of the number of shares of Class A common stock outstanding on December 31, 2020, resulting in a total of 13,545,315 shares reserved for awards under the 2020 Plan.
Future Granted number of shares (in Shares) | shares			7,863,792
Employee Stock Purchase Plan [Member]
Stock-Based Compensation (Details) [Line Items]
Employee stock purchase plan, description			Under the ESPP, eligible employees and eligible service providers of the Company or an affiliate will be granted rights to purchase shares of Class A common stock at a discount of 15% to the lesser of the fair value of the shares on the offering date and the applicable purchase date. The total number of shares of Class A common stock reserved for issuance under the ESPP initially equaled 2% of the fully diluted capitalization of the Company as of the closing of the Merger Transaction, or 1,764,916 shares. In accordance with the automatic share increase provision in the ESPP, the total number of shares of Class A common stock reserved for issuance will be automatically increased on the first day of each fiscal year, beginning with the 2021 fiscal year and ending on the first day of 2031 fiscal year, in an amount equal to lesser of (i) 1% of the total number of shares of Class A common stock outstanding on the last day of the calendar month prior to the date of such automatic increase and (ii) such number of shares as determined by the Board. No shares were added on January 1, 2021. In March 2021, the Board approved of the amendment and restatement of the ESPP to, among other things, implement an additional limitation of 1,000,000 shares of Class A common stock to the ESPP’s automatic share increase provision. The amendment and restatement of the ESPP was approved at the Company’s annual meeting of stockholders held on June 3, 2021.